31-Mar-24 | 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Africa, Near and Middle East | 78.50 | 4% | 63.60 | 3% | 53.60 | 4% | 54.10 | 4% | 63.20 | 5% |
Asia Pacific | 274.70 | 14% | 282.40 | 15% | 250.80 | 16% | 216.10 | 16% | 213.30 | 16% |
Europe | 294.00 | 14% | 376.40 | 20% | 308.10 | 20% | 276.00 | 21% | n/a | n/a |
Other countries | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 54.00 | 4% |
Unanalysed | 72.10 | 4% | 70.70 | 4% | 48.60 | 3% | 49.60 | 4% | 510.30 | 38% |
United Kingdom | 419.50 | 21% | 278.90 | 15% | 267.00 | 18% | 213.60 | 16% | 221.20 | 17% |
United States of America | 895.30 | 44% | 780.80 | 42% | 597.20 | 39% | 508.80 | 39% | 276.40 | 21% |
Total | 2,034.10 | 100% | 1,852.80 | 100% | 1,525.30 | 100% | 1,318.20 | 100% | 1,338.40 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 340.30 | 100% | 291.50 | 100% | 304.40 | 100% | 252.90 | 100% | 224.10 | 100% |
Total | 340.30 | 100% | 291.50 | 100% | 304.40 | 100% | 252.90 | 100% | 224.10 | 100% |
31-Mar-24 | 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Environmental & Analysis | 823.80 | 40% | n/a | n/a | 442.90 | 29% | 361.10 | 27% | 325.00 | n/a |
Infrastructure Safety | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 466.50 | n/a |
Medical | 658.40 | 32% | 556.40 | 30% | 442.30 | 29% | 371.30 | 28% | 347.20 | n/a |
Process Safety | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 200.00 | n/a |
Safety | 552.90 | 27% | 745.60 | 57% | 641.40 | 42% | 587.00 | 44% | n/a | n/a |
Unanalysed | (1.00) | n/a | 550.80 | n/a | (1.30) | n/a | (1.20) | n/a | n/a | n/a |
nter-segmental sales | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | (0.30) | n/a |
Total | 2,034.10 | 100% | 1,852.80 | 100% | 1,525.30 | 100% | 1,318.20 | 100% | 1,338.40 | n/a |
Profit Before Tax | ||||||||||
Environmental & Analysis | 138.00 | 34% | n/a | n/a | 96.90 | 28% | 101.70 | 36% | n/a | n/a |
Medical | 170.20 | 42% | 101.60 | 35% | 83.30 | 24% | 66.80 | 23% | n/a | n/a |
Safety | 100.80 | 25% | 123.90 | 55% | 163.50 | 48% | 117.30 | 41% | n/a | n/a |
Unanalysed | (68.70) | n/a | 66.00 | n/a | (39.30) | n/a | (32.90) | n/a | 224.10 | n/a |
Total | 340.30 | 100% | 291.50 | 100% | 304.40 | 100% | 252.90 | 100% | 224.10 | n/a |
You are here: research